Status:
UNKNOWN
Less Than 100 Hours Hospital Stay After Pancreatico-duodenectomy, RCT
Lead Sponsor:
National Cancer Institute, Egypt
Conditions:
Pancreas Cancer
Eligibility:
All Genders
20-75 years
Phase:
NA
Brief Summary
Few decades back pancreatico-duodenectomy (PD) was associated with a very high morbidity and mortality. With recent advancements in surgical and anesthetic techniques and improvement in peri-operative...
Detailed Description
Study population: This is a prospective study that will be conducted on all patients of both sexes and definite age groups attending the National Cancer Institute, Cairo University and candidate for p...
Eligibility Criteria
Inclusion
- Age ≤ 75 years
- ASA 1 or 2
- BMI \< 35
- The underlying pathology or use of neoadjuvant chemotherapy did not preclude inclusion into the study
Exclusion
- \- pancreatico-duodenectomy with vascular reconstruction.
Key Trial Info
Start Date :
December 25 2021
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
July 1 2023
Estimated Enrollment :
40 Patients enrolled
Trial Details
Trial ID
NCT05192044
Start Date
December 25 2021
End Date
July 1 2023
Last Update
January 14 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
National Cancer Institute
Cairo, Egypt, 11796